Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Ptc Therapeutics (PTCT) over the last 13 years, with Q3 2025 value amounting to 0.44%.

  • Ptc Therapeutics' Return on Capital Employed rose 5400.0% to 0.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44%, marking a year-over-year increase of 5400.0%. This contributed to the annual value of 0.25% for FY2024, which is 1200.0% up from last year.
  • As of Q3 2025, Ptc Therapeutics' Return on Capital Employed stood at 0.44%, which was up 5400.0% from 0.36% recorded in Q2 2025.
  • Ptc Therapeutics' Return on Capital Employed's 5-year high stood at 0.45% during Q1 2025, with a 5-year trough of 0.8% in Q3 2023.
  • Its 5-year average for Return on Capital Employed is 0.21%, with a median of 0.26% in 2021.
  • In the last 5 years, Ptc Therapeutics' Return on Capital Employed crashed by -5400bps in 2023 and then skyrocketed by 7400bps in 2025.
  • Quarter analysis of 5 years shows Ptc Therapeutics' Return on Capital Employed stood at 0.26% in 2021, then plummeted by -42bps to 0.36% in 2022, then fell by -24bps to 0.45% in 2023, then soared by 44bps to 0.25% in 2024, then surged by 273bps to 0.44% in 2025.
  • Its Return on Capital Employed stands at 0.44% for Q3 2025, versus 0.36% for Q2 2025 and 0.45% for Q1 2025.